choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Paclitaxel & Brain Tumor

Paclitaxel & Brain Tumor Newsletter
  • Lisata (LSTA) Q3 2025 Earnings Call Transcript 09 Nov 2025 07:46 GMT

    … care gemcitabine and nab-paclitaxel chemotherapy in patients with … with gemcitabine and nab-paclitaxel as a treatment for … care gemcitabine and nab-paclitaxel chemotherapy versus cerdepatide in … multiforme, or GBM, brain cancer has been initiated with …

  • Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q3 2025 Earnings Call Transcript 08 Nov 2025 13:21 GMT

    … care gemcitabine and nab-paclitaxel chemotherapy in patients with … with gemcitabine and nab-paclitaxel as a treatment for … care gemcitabine and nab-paclitaxel chemotherapy versus certepetide in … multiforme, or GBM, brain cancer has been initiated with …

  • Advances in Brain Tumor Therapy Based on the Magnetic Nanoparticles 20 Dec 2023 04:36 GMT

    brain tumors (Figure 1). Figure 1 Overview of magnetic nanoparticles (MNPS) for brain tumorbrain tumor barrier for delivery of magnetic hyperthermia to brain cancer … tumour barrier in brain tumours and metastases. … tumors of multifunctional paclitaxel/SPIO …

  • Drug-delivery technique with vessel-targeted gold nanoparticles shows growing promise for brain cancer treatment 16 Oct 2023 15:57 GMT

    … the most common human brain cancer. The researchers demonstrated … experiments, researchers used paclitaxel, a chemotherapy drug … al, Optical blood-brain-tumor barrier modulation expands … shows growing promise for brain cancer treatment (2023, October …

  • Drug-Delivery Technique for Brain Cancer Shows Growing Promise 13 Oct 2023 05:00 GMT

    … the most common human brain cancer. The researchers demonstrated the … is an aggressive brain cancer that affects about 12 … their experiments, researchers used paclitaxel, a chemotherapy drug used … for potential use against brain cancer because, on its …

  • Biodegradable ultrasound implant could improve brain tumour treatments 07 Jul 2023 09:24 GMT

    … outcomes for patients with brain cancer. Researchers led by … that could help treat brain tumours. Brain tumours are particularly difficult … the chemotherapy drug paclitaxel significantly extended the … most aggressive form of brain tumour) compared with mice …

  • This Dissolving Implant May One Day Save Lives From Brain Cancer 16 Jun 2023 00:15 GMT

    … and chemotherapy. However, brain cancers are notably resistant to … one time, even though brain cancers often need multiple bouts … brain cancer, who were treated with a chemotherapy drug called paclitaxel, … barrier and cause the brain tumor to shrink and let …

  • Ultrasound implant helps deliver powerful chemotherapy to brain tumours 09 Jun 2023 12:31 GMT

    … of malignant brain tumours challenging. The drug paclitaxel, for example … Northwestern Medicine Malnati Brain Tumor Institute, and colleagues … -bound paclitaxel infusion leads to paclitaxel concentrations … of albumin-bound paclitaxel plus carboplatin following …

  • Breakthrough: New Gel Shown to Be Effective for Brain Tumour Treatment 29 May 2023 15:31 GMT

    … great promise for brain tumour treatment during lab tests … most aggressive forms of brain tumour, glioblastoma, leaving patients … the approved drug paclitaxel which then transports the … thereby killing it off. Brain Tumour Treatment: Glioblastoma – aggressive …

  • New Gel Stops Brain Tumors in Mice 17 May 2023 21:01 GMT

    … of mice with an aggressive brain cancer called glioblastoma. The gel, which … the grooves left after a brain tumor is surgically removed. The gel … vehicle to deliver the drug paclitaxel and a specific antibody. They …

Satisfied with the content?

Continue to create your account.